Insight
Legal Compliance for Telehealth Platforms in Australia
06 Nov 2026
In short
Operating an Australian telehealth platform requires navigating strict health data privacy rules, medical board practitioner standards, and therapeutic goods advertising restrictions. Platform operators must also structure clinical service agreements carefully to mitigate liability and payroll tax risks.
Telehealth platforms operating in Australia face a converging matrix of health practitioner regulation, privacy law, and therapeutic goods restrictions. Whether delivering asynchronous text-based consults or synchronous video appointments, operators must clearly delineate between providing digital software infrastructure and delivering clinical healthcare services.
Structuring the platform: Technology facilitator or healthcare provider
The threshold legal issue for any digital health venture is defining its commercial and operational structure. Most platforms seek to position themselves as technology facilitators that merely license software, booking infrastructure, and administrative support to independent medical practitioners. This distinction determines medical negligence exposure, statutory obligations, and state payroll tax liability.
If your platform exercises clinical control over practitioners—such as dictating consultation lengths, mandating specific treatment outcomes, or restricting clinical autonomy—courts and regulators will treat the platform as a healthcare provider rather than a software vendor. Contracts must reflect this separation precisely. Platforms should use a robust service agreement that establishes an administrative services arrangement, confirming that practitioners retain absolute clinical independence and carry their own medical indemnity insurance.
State revenue offices scrutinise these arrangements under contractor provisions for payroll tax. Following recent Australian case law concerning medical centres, platforms that collect patient fees centrally and remit net amounts to doctors risk assessments that these payments constitute taxable wages. Telehealth platforms must structure their payment flows, trust accounts, and commercial terms to ensure practitioner billings are not characterised as deemed wages paid by the platform.
AHPRA guidelines and practitioner prescribing standards
Telehealth platforms must operate within the regulatory framework established by the Medical Board of Australia and the Australian Health Practitioner Regulation Agency (AHPRA). The Medical Board's updated telehealth guidelines impose explicit standards on doctors consulting remotely, directly impacting platform workflow design.
A critical requirement is that practitioners must conduct a real-time (synchronous) consultation via video or audio before prescribing medication, unless an established clinical relationship already exists. Platforms built entirely around asynchronous questionnaires—where patients complete an online form and a doctor issues a prescription without direct interaction—face severe regulatory exposure. AHPRA considers purely questionnaire-based prescribing to fall below acceptable professional standards in almost all non-emergency scenarios.
Platform onboarding processes must actively verify each practitioner's AHPRA registration, conditions, and notations. The software must also accommodate practitioner obligations to verify patient identity, assess whether telehealth is clinically appropriate for the presenting condition, and ensure continuity of care through clinical record-keeping and communication with the patient's regular general practitioner.
Navigating TGA restrictions on advertising prescription medications
Digital health operators in verticals such as weight loss, hair loss, medicinal cannabis, and erectile dysfunction frequently breach federal therapeutic goods laws. Under the Therapeutic Goods Act 1989, it is an offence to advertise prescription-only (Schedule 4 and Schedule 8) substances directly to Australian consumers.
The Therapeutic Goods Administration (TGA) interprets advertising broadly. Any promotional material that references specific prescription medications, active ingredients, or brand names—or uses language that leads consumers to anticipate a specific drug prescription—breaches the legislation. This restriction captures website landing pages, social media marketing, digital intake forms, and search engine advertising.
To maintain compliance, platforms must promote consultations for health conditions rather than pharmaceutical treatments. For example, marketing a "doctor-led medical consultation for metabolic health" is permissible; advertising access to specific GLP-1 receptor agonists is illegal. Platforms operating subscription models must ensure advertising focuses entirely on the clinical consultation and ongoing practitioner support, rather than the supply of scheduled medicines.
Privacy Act obligations and handling sensitive health information
Health information is categorised as sensitive information under the Privacy Act 1988, attracting the highest degree of protection under the Australian Privacy Principles. Notably, the standard small business exemption under the Privacy Act does not apply to any business that provides a health service and holds health information. Even pre-revenue healthtech startups must comply fully with federal privacy legislation.
Telehealth platforms must obtain express, informed consent before collecting, using, or disclosing health information. This requires a dedicated privacy policy tailored to clinical workflows, addressing how consultation notes, pathology referrals, and electronic scripts are created, transferred, and stored. Forward-looking operators should also audit their data architecture against upcoming privacy law reforms, which introduce heightened individual rights and stricter transparency requirements.
Data security is an acute commercial and regulatory risk. Platforms must implement end-to-end encryption for video feeds, role-based access controls for electronic medical records, and secure integrations with prescription delivery systems such as electronic script exchanges. Operators must maintain a tested data breach response plan to satisfy mandatory reporting obligations to the Office of the Australian Information Commissioner (OAIC) in the event of an eligible breach.
Synchronous versus asynchronous telehealth models
Australian regulators treat direct communication and automated intake differently. The table below outlines how legal risk profiles differ between consultation models.
| Regulatory Factor | Synchronous Consultations (Video / Audio) | Asynchronous Models (Forms / Algorithms) |
|---|---|---|
| Medical Board Compliance | Meets standard consultation requirements if clinical evaluation is adequate. | High regulatory risk if used for standalone prescribing without direct interaction. |
| Prescription Legality | Permissible across Schedule 4 medications subject to clinical necessity. | Strictly restricted; questionnaire-only scripts breach AHPRA and state pharmacy rules. |
| Informed Consent | Obtained verbally and documented directly within the consultation record. | Requires granular click-through mechanisms and explicit disclosures prior to intake. |
| TGA Advertising Risk | Low, provided platform marketing focuses on medical access rather than drug brands. | Very high, as questionnaires often funnel users toward pre-selected medications. |
Practical compliance steps for telehealth platform founders
To establish a defensible telehealth business in Australia, founders and platform executives should implement the following steps during product design and commercial launch:
- Draft clinical-grade terms and conditions: Establish clear boundaries between platform software and medical care. Include express terms concerning emergency exclusions, clinical disclaimers, and user identity verification.
- Audit marketing and intake funnels: Review every patient touchpoint to remove references to prescription drug names, brand derivatives, and therapeutic claims that violate TGA advertising codes.
- Implement compliant doctor onboarding agreements: Ensure your agreements with doctors establish arm's-length contractor relationships, require current medical indemnity cover, and maintain practitioner discretion to refuse prescriptions.
- Secure data storage and integration points: Ensure patient data resides on Australian-based cloud infrastructure complying with Australian privacy laws, and verify that third-party integrations (such as e-prescribing or pharmacy dispensing APIs) handle health records securely.
- Review patient subscription contracts: Telehealth platforms using membership or recurring subscription models must review cancellation terms and billing rules to ensure compliance with Australian Consumer Law and unfair contract terms legislation.
Addressing these regulatory requirements early prevents costly regulatory enforcement, protects intellectual property, and prepares your venture for external due diligence when raising seed or venture capital.
Frequently asked questions
Can an Australian telehealth platform prescribe medication without a video call?
Under Medical Board of Australia guidelines, practitioners must generally conduct a real-time consultation via video or telephone before prescribing medication. Purely text-based, asynchronous questionnaires that result in a prescription without live doctor-patient interaction fail to meet professional standards and place practitioners and platforms at serious regulatory risk.
Are healthtech startups exempt from the Privacy Act if turnover is under $3 million?
No. The Privacy Act 1988 removes the small business turnover exemption for any business that provides a health service or collects health information. Telehealth startups of any size must comply fully with the Australian Privacy Principles from the date they begin collecting patient data.
Can a telehealth platform advertise weight loss or hair loss medications online?
No. The Therapeutic Goods Act 1989 prohibits advertising prescription-only medicines directly to consumers. Telehealth platforms may advertise medical consultations for specific health conditions, but referencing brand names, active pharmaceutical ingredients, or guaranteeing medication outcomes breaches federal law.
Does a telehealth company need to pay payroll tax on doctor billings?
If the platform's contracts, fee flows, or operational controls cause the arrangement to be categorised as a relevant contract for payroll tax purposes, state revenue offices may assess practitioner billings as taxable wages. Platforms must carefully structure payment mechanisms and administrative service terms to manage this risk.
Two ways to start
Get a fixed fee before any work starts.
Answer a few short questions, attach your documents if you have them, and a senior lawyer replies with the scope and the price.
Know what you need? Request a fixed-fee quote and upload your documents. Not sure of scope? Book a short call with a senior lawyer instead.